Bulgaria - Burgas: Pharmaceutical products

ID

ocds-pyfy63:2017-492003:2017-492003

Buyer

„Kompleksen onkologichen tsentar — Burgas“ EOOD

Date

2017-12-09

Language

BG

Tags

tender

Release in JSON

ID (OCID)

ocds-pyfy63:2017-492003

Releases

2017-12-09 (ocds-pyfy63:2017-492003:2017-492003)
2017-12-23 (ocds-pyfy63:2017-492003:2017-518789)
2018-03-13 (ocds-pyfy63:2017-492003:2018-110437)

Releases in JSON

Title

Bulgaria - Burgas: Pharmaceutical products

Award criteria

priceOnly

Award criteria details

Lowest price

Award criteria for item 1:
- Price

Award criteria for item 2:
- Price

Award criteria for item 3:
- Price

Award criteria for item 4:
- Price

Award criteria for item 5:
- Price

Award criteria for item 6:
- Price

Award criteria for item 7:
- Price

Award criteria for item 8:
- Price

Award criteria for item 9:
- Price

Award criteria for item 10:
- Price

Award criteria for item 11:
- Price

Award criteria for item 12:
- Price

Award criteria for item 13:
- Price

Award criteria for item 14:
- Price

Award criteria for item 15:
- Price

Award criteria for item 16:
- Price

Award criteria for item 17:
- Price

Award criteria for item 18:
- Price

Award criteria for item 19:
- Price

Award criteria for item 20:
- Price

Award criteria for item 21:
- Price

Award criteria for item 22:
- Price

Award criteria for item 23:
- Price

Award criteria for item 24:
- Price

Award criteria for item 25:
- Price

Award criteria for item 26:
- Price

Award criteria for item 27:
- Price

Award criteria for item 28:
- Price

Award criteria for item 29:
- Price

Award criteria for item 30:
- Price

Award criteria for item 31:
- Price

Award criteria for item 32:
- Price

Award criteria for item 33:
- Price

Award criteria for item 34:
- Price

Award period

2018-01-09 - ?

Eligibility criteria

Suitability:

Участник в процедурата за възлагане на обществената поръчка може да бъде всяко физическо или юридическо лице, което има право да извършва дейност — производство, внос или търговия (алтернативно) с лекарствени продукти по предмета на поръчката, както и техни обединения съгласно законодателството на държавата, в която лицето е установено. Участниците да са регистрирани като търговци по българското законодателство или по законодателство на държава — членка на Европейския съюз или държава — страна по Споразумението за Европейското икономическо пространство и да имат право да извършват:
— търговия на едро с лекарствени продукти в съответствие с нормите на ЗЛПХМ. Участниците следва да притежават валидно Разрешение за търговия на едро и/или внос на лекарствени продукти, издадено от ИАЛ или регулаторен орган на друга държава членка по реда на глава девета на ЗЛПХМ — Търговия на едро с лекарствени продукти,
— търговия на едро с лекарствени продукти, съдържащи наркотични вещества, съгл. сп. II и III по чл. З, т. 2 и т. З от Наредба за реда за класифициране на растенията и веществата като наркотични в съответствие с нормите на ЗКНВП, когато участват за ЛП от ОП №№ 25,27,34. Участниците следва да притежават валидна Лицензия, издадена по реда на чл. 32 от ЗКНВП.
За доказване на съответствието с посочените изисквания, участниците следва да посочат необходимата информация в ЕЕДОП — т. 1) на таблица А: „Годност“, част IV „Критерии за подбор“.
Документи за доказване: представят се при подписване на договор или при изискване от комисията, назначена за провеждане на процедурата — заверено от участника копие на:
— Разрешение за търговия на едро с лекарствени продукти; или Удостоверение за регистрация за търговия на едро на територията на Р България на лицата, притежаващи разрешение за тази дейност, издадено от регулаторен орган на съответната държава членка; или Разрешение за внос; или Разрешение за производство, издадени по реда на ЗЛПХМ,
— валидна Лицензия, издадена по реда на чл. 32 от ЗКНВП — за ОП №№ 25,27,34.

Economic/financial eligibility:

Няма.

Economic/financial minimum level:

Не се изисква.

Technical/professional eligibility:

Няма.

Technical/professional minimum level:

Не се изисква.

Main procurement category

goods

Procurement method

open

Procurement method details

Open procedure

Tender period

2017-12-09 - 2018-01-09

Value

589 766.89 BGN

Minimum value

589 766.89 BGN

ID

ocds-pyfy63:2017-492003:obj:1

Classification

CPV / 33600000

Description

Ranitidine solution for injection 50 mg, 2 000.
Famotidine solution for injection 20 mg, 18 000.
Esomeprazole powder for solution for injection/infusion 40 mg, 50.

ID

ocds-pyfy63:2017-492003:obj:2

Classification

CPV / 33600000

Description

A03AD01 Papaverine solution for injection 20 mg — 200.
A03BA01 Atropine solution for injection 1 mg — 800.
A03BB01 Butylscopolamine solution for injection 20 mg — 200.

ID

ocds-pyfy63:2017-492003:obj:3

Classification

CPV / 33600000

Description

A03FA01 Metoclopramide solution for injection 10 mg, 6 000.
A04AA01 Ondansteron solution for injection 2 mg/ml — 4 ml, 9 000.
A04AA05 Palonosetron solution for injection 0,05 mg/ml — 5 ml, 30.

ID

ocds-pyfy63:2017-492003:obj:4

Classification

CPV / 33600000

Description

A16AA02 Ademetionine powd. inj.+solv 500 mg, 1 500.
A16AA02 Ademetionine tabl. gastr. res 500 mg, 100.
A05BA00 L-Ornithine-L-Aspartate Concentrate for solution for infusion 5 000 mg/10 ml, 500.

ID

ocds-pyfy63:2017-492003:obj:5

Classification

CPV / 33600000

Description

A10AB01 Insulin Human solution injection 300 UI, 160.
A10AB01 Insulin Human suspention injection 300 UI, 30.
B05CX01 Glucose Solution for injection 40 % — 10 ml, 150.

ID

ocds-pyfy63:2017-492003:obj:6

Classification

CPV / 33600000

Description

A11GA01 Ascorbic acid solution injection 500 mg, 6 000.
A12AA03 Calcium gluconate, Calcium Laevulinate solution for injection 8,94 mg /ml — 10ml, 1 200.

ID

ocds-pyfy63:2017-492003:obj:7

Classification

CPV / 33600000

Description

B01AB06 Nadroparin solution for injection 3 800 IU, 5 000.
B01AB06 Nadroparin solution for injection 5 700 IU, 1 000.

ID

ocds-pyfy63:2017-492003:obj:8

Classification

CPV / 33600000

Description

B01AB05 Enoxaparin sodium sol. inj., pre-filled syr. 4 000 IU/0,4 ml, 500.
B01AB12 Bemiparin sodium solution for injection 3 500 IU, 100.

ID

ocds-pyfy63:2017-492003:obj:9

Classification

CPV / 33600000

Description

A06AD65 Macrogol, combinations powd. for susp. 64 g, 2 600.
A06AD65 Macrogol, combinations powder for oral solution 52, 5g, 2 600.

ID

ocds-pyfy63:2017-492003:obj:10

Classification

CPV / 33600000

Description

B05AA01 Albumin solution for infusion 20 % — 100 ml, 350.
B05AA01 Albumin sol. inf. vial 20 % — 50 ml, 300.

ID

ocds-pyfy63:2017-492003:obj:11

Classification

CPV / 33600000

Description

B05BA10 Ol. Olivarum 15 %, Amino acid sol. 6.3 %,+E; Glucose sol. 18.75 % emulsion for infusion 2 000 ml, 100.
B05BB01 Electrolytes (Magnesium chloride hexahydrate 0,3 g; Sodium chloride 5,26 g; Potassium chloride 0,37 g; Sodium acetate trihydrate 3,68 g; Sodium Gluconate 5,02 g/l) solution for infusion /PH 7,4/ — 1 000 ml, 2 000.
B05BB01 Electrolytes (Magnesium chloride hexahydrate 0,3 g; Sodium chloride 5,26 g; Potassium chloride 0,37 g; Sodium acetate trihydrate 3,68 g; Sodium Gluconate 5,02 g/l) solution for infusion /PH 7,4/ — 500 ml, 6 000.
B05BC01 Mannitol sol. for inf. 100 g/l — 500 ml, 1 000.
V06DC01 Glucose/Sodium chloride solution for infusion 50 g/9 g/l — 1 000 ml, 500.
B05CB01 Sodium chloride sol.for inf. /glass/ 0,9 % — 250 ml, 500.

ID

ocds-pyfy63:2017-492003:obj:12

Classification

CPV / 33600000

Description

B01AB01 Heparin solution for injection 25 000 IU, 30.
B05XA01 Potassium chloride solution for injection 1 500 mg, 1 400.
B05XA03 Sodium chloride solution for injection 9 mg/ml — 10 ml, 5 000.
B05XB02 Alanyl glutamine concentrate for solution for infusion 200 mg/ml —100 ml, 100.
B05BA01 Amino Acids /Isoleucine, Leucine, Lysine, Methionine, Phenylalanine, Threonine, Tryptophan, Valine, Arginine, Histidine, Alanine, Glycine, Proline, Serine, Tyrosine, Taurine/ solution for infusion 10 % — 500 ml, 300.
B05BA01 L-Serine, L-Isoleucine, L-Leucine, L-Lysine monoacetate, L-Methionine, L-Phenylalanine, L-Threonine, L-Tryptophan, L-Valine, L-Alanine, L-Arginine, Glycine, L-Histidine, L-Proline, N-acetyl-L-Cysteine, Acetic acid 99 % Hepa 8 % 500 ml Solution for infusion 8 % — 500 ml, 300.
B05BА10 Glucose, L-alanine, L-arginine, L-aspartic acid, L-glutamic acid, Glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionone, L-phenylalanine, L-proline, L-serine, L-threonine, L-tryptophan, L-tyrosine, L-valine, Calcium Chloride, Sodium glycer emulsion for intravenous infusion 1 440 ml, 100.
B05BA10 Glucose, L-alanine; L-arginine; L-aspartic acid; L-glutamic acid; Glycine; L-histidine; L-isoleucine; L-lysine; L-methionine; L-phenylalanine; L-proline; L-serine; L-threotine; L-tryptophan; L-tyrosine; L-valine; Calcium chloride; sodium glycerophosphate; emulsion for infusion 1 540 ml, 20.
B05XA02 Sodium hydrogen carbonate concentrate for solution for infusion 1 680 mg, 50.

ID

ocds-pyfy63:2017-492003:obj:13

Classification

CPV / 33600000

Description

B05BB01 Calcium chloride/Potassium chloride/Sodium chloride solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 0.33 g/0.3 g/8.6 g/l — 500 ml, 6 000.
B05BB01 Calcium chloride/Potassium chloride/Sodium chloride solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 0.33 g/0.3 g/8.6 g/l — 1 000 ml, 500.
B05CX01 Glucose 10 % solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 500 ml, 3 000.
B05CX01 Glucose 5 % solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 500 ml, 6 000.
C05BB56 Glucose/Sodium chloride solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 50 g/9 g/l — 500 ml, 5 200.
B05AA07 Hydroxyethylstarch (1 000 ml инфузионен разтвор съдържа: sodium chloride — 9 g; Poly starch — 100 g) solution for infusion 500 ml, 300.
B05AA07 Hydroxyethylstarch (1 000 ml инфузионен разтвор съдържа: sodium chloride — 9g; Poly starch — 60g) solution for infusion 500 ml, 300.
B05BC01 Mannitol solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 150 g/l — 500 ml, 2 000.
B05CB01 Sodium chloride solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 0,9 % — 100 ml, 10 000.
B05CB01 Sodium chloride solution for infusion(LDPE), двупътен стерилен порт със самозапечатващи се портове 0,9 % — 250 ml, 4 000.
B05CB01 Sodium chloride solution for infusion(LDPE), двупътен стерилен порт със самозапечатващи се портове 0,9 % — 500 ml, 21 000.
B05CB01 Sodium chloride solution for infusion(LDPE), двупътен стерилен порт със самозапечатващи се портове 0,9 % — 1 000 ml, 3 000.
B05BB01 Sodium chloride/Potassium chloride/Calcium chloride dihydrate/Sodium lactate solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 500 ml, 200.

ID

ocds-pyfy63:2017-492003:obj:14

Classification

CPV / 33600000

Description

J01CR02 Amoxicillin/Clavulanic acid tabl. film-coated 875 mg/125 mg, 500.
J01CR02 Amoxicillin/Clavulanic acid powder for solution for injection 1000 mg/200 mg, 50.
J01DD01 Cefotaxime powder for solution for injection/infusion 1g, 40.
J01FA10 Azithromycin powder for solution for infusion 500 mg, 50.
J01FA10 Azithromycin tabl. film-coated 500 mg, 70.
J01GB03 Gentamicin solution for injection 40 mg/ml — 2 ml, 350.
J01MA02 Ciprofloxacin tabl. film-coated 500 mg, 600.
J01MA12 Levofloxacin film-coated tablets 500 mg, 80.
J01XA02 Teicoplanin powd. and solv. for solution for injection 400 mg, 50.
J01XB01 Colistimethate sodium powder for solution for injection or infusion 1 MIU, 50.

ID

ocds-pyfy63:2017-492003:obj:15

Classification

CPV / 33600000

Description

J01DB04 Cefazolin powder for solution for injection 2 000 mg, 50.
J01DA00 Cefoperazon/Sulbactam powder for solution for injection 1 g/1 g, 2 000.
J01DD12 Cefoperazone powder for solution for injection 2 000 mg, 30.
J01DD02 Ceftazidime powder for solution for injection 1 000 mg, 40.
J01DD04 Ceftriaxone powder for solution for injection 1 g, 300.
J01DD04 Ceftriaxone powder for solution for injection 2 g, 3 000.
J01DC02 Cefuroxime powd. inf. 1 500 mg, 600.
J01DH02 Meropenem powder for solution for injection 1 000 mg, 500.
J01CR05 Piperacillin/ Tazobactam powder for solution for injection or infusion 4 g/0,5 g, 20.
J01XA01 Vancomycin powder for solution for infusion 1 000 mg, 20.
J02AC03 Voriconazole powder for solution for infusion 200 mg, 20.

ID

ocds-pyfy63:2017-492003:obj:16

Classification

CPV / 33600000

Description

J01MA02 Ciprofloxacin hydrochloride solution for infusion 100 mg/10 ml, 1 000.
J01FF01 Clindamycin solution for injection 150 mg/ml — 4 ml, 40.
J02AC01 Fluconazole solution for injection 2 mg/ml — 100 ml, 350.
J01GB06 Amikacin solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 10 mg/ml — 100 мл, 50.
J01GB06 Amikacin solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 2,5 mg/ml — 100 мл, 100.
J01GB06 Amikacin solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 5 mg/ml — 100 мл, 100.
J01GB06 Amikacin solution for injection 500 mg/2 ml — 2 ml, 600.
J01MA12 Levofloxacin solution for infusion 5 mg/ml — 100 ml, 150.
J01XX08 Linezolid solution for infusion 2 mg/ml — 300 ml, 50.
J01XD01 Metronidazole solution for infusion 500 mg — 100 ml, 2 700.
J01DH51 Imipenem /Cilastatin powder for solution for infusion 500 mg/ 500 mg, 50.

ID

ocds-pyfy63:2017-492003:obj:17

Classification

CPV / 33600000

Description

B05BA10 Combinations Amino Acids 72 g, Lipids 75 g, Glucose 225 g emulsion for infusion 1 875 ml, 30.
B05BA10 Combinations Amino Acids 60 g, LIpids 75 g, Glucose 120 g emulsion for infusion 1 875 ml, 30.
B05AA06 Gelatin agents — Колоиден 4 % разтвор на модифициран течен желатин за обезмаслителна терапия, изотоничен с напълно балансиран електролитен състав, 500 мл solution for infusion (LDPE), двупътен стерилен порт със самозапечатващи се портове 4 % 500 ml, 150.
B05XX Trace elements, Combinations concentrate for sol. for infus. 10 ml, 300.

ID

ocds-pyfy63:2017-492003:obj:18

Classification

CPV / 33600000

Description

C01AA05 Digoxin sol. Inj./inf. 0.5 mg/2 ml, 150.
C01BB01/ N01BB02 Lidocaine solution for injection 20 mg/ml — 10 ml, 1 000.
C01BD01 Amiodarone solutio for intravenous infusion 50 mg/ml — 3 ml, 250.
C01CA04 Dopamine Hydrochloride concentrate for solution for infusion 40 mg/ml — 5 ml, 100.
C01CA24 Epinephrine solution for injection 1mg/ml — 1 ml, 100.
C01DA02 Glyceryl trinitrate solution for infusion 1 mg/ml — 50 ml, 60.
C02AC01 Clonidine solution for injection 0,15 mg, 800.
C03CA01 Furosemide solution for injection 10 mg/ml — 2 ml, 2 000.
C03CA04 Torasemide tablet 10 mg, 450.
C03CA04 Torasemide solution for injection 20 mg/4 ml, 300.
C03CA04 Torasemide solution for injection 10 mg/2 ml, 3 000.

ID

ocds-pyfy63:2017-492003:obj:19

Classification

CPV / 33600000

Description

N01BB52 Lidocaine/Chlohexidine urethral gel 0,25 g Lidocaine 1 000.
N01BB52 Lidocaine/Chlohexidine urethral gel 0,17 g Lidocaine 200.
D08AG02 Povidone-iodine cut. sol 7,5 g/100 g — 1 000 ml, 100.
D08AG02 Povidone-iodine ointment 10 % — 100 g, 100.
D08AG02 Povidone-iodine ointment 10 % — 250 g, 50.

ID

ocds-pyfy63:2017-492003:obj:20

Classification

CPV / 33600000

Description

H01BA04 Terlipressin solution for injection 0,1 mg/ml — 2 ml, 800.
H02AB02 Dexamethasone solution for injection 4 mg, 35 000.
H02AB04 Methylprednisolone Lyophilisate for solution for injection 15,78 mg, 2 000.
H02AB04 Methylprednisolone Lyophilisate for solution for injection 40 mg, 3 200.
H02AB04 Methylprednisolone Lyophilisate for solution for injection 125 mg, 150.

ID

ocds-pyfy63:2017-492003:obj:21

Classification

CPV / 33600000

Description

M03AC04 Atracurium solution injection 10 mg/ml — 2,5 ml, 300.
M03AC04 Atracurium solution injection 10 mg/ml — 5 ml, 800.
M03AC06 Pipecuronium bromide powder and solvent for solution for injection 4 mg, 100.
M03AB01 Suxamethonium solution for injection 10 mg/ml — 5 ml, 1 700.

ID

ocds-pyfy63:2017-492003:obj:22

Classification

CPV / 33600000

Description

M01AB05 Diclofenac sodium solution for injection 75 mg/3 ml, 500.
M01AB05 Diclofenac; Orphenadrine citrate solution for infusion 75mg/30mg — 250 ml, 500.
A03AD02 Drotaverine solution for injection 40 mg, 3 300.
N02BB02 Metamizole sodium solution for injection 1 000 mg/2 ml, 4 500.
N02BE01 Paracetamol solution for infusion 1 000 mg/100 ml, 300.

ID

ocds-pyfy63:2017-492003:obj:23

Classification

CPV / 33600000

Description

N01BB09 Ropivacaine hydrochloride solution for injection 5 mg/ml 10 ml 300.
N01BB09 Ropivacaine hydrochloride solution for injection 7,5 mg/ml 10ml 100.
N01AX10 Propofol emulsion for injection/ infusion 200mg/20ml 1 000.
N01AB08 Sevoflurane inhalation liquid 250ml 100.

ID

ocds-pyfy63:2017-492003:obj:24

Classification

CPV / 33600000

Description

M01AE03 Ketoprofen solution for injection 100 mg, 200.
M01AE17 Dexketoprofen solution for injection 50 mg, 5 000.
M01AH04 Parecoxib powd. and solv. for sol. inj. 40 mg, 50.

ID

ocds-pyfy63:2017-492003:obj:25

Classification

CPV / 33600000

Description

N05AA01 Chlorpromazine solution injection 50 mg/2 ml ,200.
N05AA01 Chlorpromazine solution injection 50 mg/5 ml, 150.
N05BA01 Diazepam solution for injection 10 mg/2 ml, 500.
N05BA12 Alprazolam tablet 0,5 mg, 2 000.
N05CD08 Midazolam solution for injection 5 mg/ml — 3 ml, 350.

ID

ocds-pyfy63:2017-492003:obj:26

Classification

CPV / 33600000

Description

N06BX03 Piracetam solution for injection 3 000 mg/15 ml, 150.
N06DA04 Galantamine solution for injection 10 mg/ml — 1 ml, 1 500.

ID

ocds-pyfy63:2017-492003:obj:27

Classification

CPV / 33600000

Description

N01AH01 Fentanyl solution for injection 0,25 mg/5 ml, 1 000.
N01AX03 Ketamine solution for injection 500 mg/10 ml, 20.
N02AB02 Pethidine solution for injection 100 mg/2 ml, 300.
N02AX02 Tramadol solution for injection 100 mg/2 ml, 7 000.

ID

ocds-pyfy63:2017-492003:obj:28

Classification

CPV / 33600000

Description

R03CB02 Bromhexine syrup 4 mg/5 ml — 125 ml, 50.
R03DA05 Aminophylline solution for injection 24 mg/ml — 10 ml, 600.
R05CB02 Bromhexine solution for injection 2 mg/ml — 2 ml, 2 000.
R05CB02 Bromhexine tabl. 8 mg, 760.
R06AC03 Chloropyramine solution for injection 10 mg/ml — 2 ml, 4 500.
R06AD02 Promethazine solution for injection 25 mg/ml — 1 ml, 120.

ID

ocds-pyfy63:2017-492003:obj:29

Classification

CPV / 33600000

Description

V03AB15 Naloxone solution for injection 0,4 mg/ml — 1 ml, 40.

ID

ocds-pyfy63:2017-492003:obj:30

Classification

CPV / 33600000

Description

J06BA02 Immunoglobuline, normal human for intravascular adm. solution for infusion 50 mg/ml — 5 ml, 80.

ID

ocds-pyfy63:2017-492003:obj:31

Classification

CPV / 33600000

Description

B02BA01 Phytomenadione solution for injection 10 mg, 160.
B03AC02 Saccharated Iron Oxid solution for injection 100 mg, 160.
B03AC06 Iron (III) — hydroxide dextran complex solution for injection 50 mg/ml — 2 ml, 100.

ID

ocds-pyfy63:2017-492003:obj:32

Classification

CPV / 33600000

Description

V08AB10 Iomeprol solution for injection 350 mg/ml — 100 ml, 200.
V08AB10 Iomeprol solution for injection 350 mg/ml — 50 ml, 400.
V08AB04 Iopamidol solution for injection 370 mg/ml — 50 ml, 40.
V08AB04 Iopamidol solution for injection 370 mg/ml — 100 ml, 40.
V08AB05 Iopromide solution for injection/infusion 370 mg/ml — 100 ml, 500.

ID

ocds-pyfy63:2017-492003:obj:33

Classification

CPV / 33600000

Description

V08CA09 Gadobutrol Solution for injection 1 mmol/ml — 7,5 ml, 200.

ID

ocds-pyfy63:2017-492003:obj:34

Classification

CPV / 33600000

Description

Ambroxol 30 mg/5 ml — 100 ml syr 30.
Ampicillin 1 g Powder for sol. for inject 500.
Amoxicillin 1 000 mg tabl. 500.
Barium sulfate 100 g pulvis 100.
Betamethasone (as Beta-methasone dipropionate) 0,05 % X 15g oint 20.
Bisacodyl 10 mg supp 30.
Carbaethopendecine bromi-de; Boric acid; Sodium tetraborate decahydrate 10 ml drops eye 30.
Copper gluconate, Ferrous gluconate, Manganese gluconate 50 mg/1,33 mg/0,70 mg Solution for injection 300.
Chloropyramine 1 % — 18g oint 30.
Dexamethasone 0,28 mg/g — 16,25 g spray 30.
Dexketoprofen trometamol 25 mg tabl 300.
Diazepam 10 mg tabl 500.
Drotaverine 40 mg tabl 1 000.
Ephedrine 50 mg/ml — 1 ml amp. 30.
Etamsylate 250 mg/2 ml solut. for inject 3 000.
Ethacridinelactate 0,1 % — 1000 ml sol 60.
Ethanol 70 % — 1 000ml sol 200.
Ethanol 95 % — 1 000ml sol 800.
Flumazenil 0,5 mg/5ml solution for inject/inf 30.
Gentamicin 0,1 % — 15 g cream 10.
Hydrogen peroxide 3 % — 1000 ml sol 80.
Iodine 5 % — 1 000 ml sol 10.
Lactulose 67 g/100 ml — 15 ml sach 350.
Lavandulae oleum 1 % — 1 000 ml sol 30.
Lidocaine 10 % — 38 g spray 20.
Loperamide 2 mg caps 1 800.
Metamizolum 1 g, Fenpriverini bromidum 40 mcg, Pitofenoni hydrochloridum 4 mg 2 ml. amp. 150.
Miconazole 20 mg/g 40 g oral gel 20.
Neomycin 11,72 mg/g — 32 g spray 30.
Nimesulide 100 mg gran. 250.
Norfloxacin 400 mg tabl 2 200.
Otilonium bromide 40 mg film-coated tablets 300.
Oxytetracycline; Hydrocortisone 9,30 mg/g +3,10 mg/g — 32,25 g ml cutaneous suspension 30.
Paracetamol 500 mg tabl 2 000.
Retinol; Ergocalciferol; Cod-liver oil; Peru Balsam; 350 IU/400 IU/g х 18 g oint 150.
Saccharomyces Boulardii 250 mg capsules 1 200.
Senna glycosides 75 ml sol 20.
Sultamicillin (Ampicillin; Sulbactam) 1 000 mg/5 00 mg powder for solut. for inject 1 600.
Validolum 60 mg tabl 200.
Zolpidem 10 mg tabl. 700.

Roles

buyer

Organization name

„Kompleksen onkologichen tsentar — Burgas“ EOOD

Street address

bul. „Stefan Stambolov“ No. 73, Hirurgichen korpus na „MBAL — Burgas“ AD, et. 7

Locality

Burgas

Postal code

8000

Country

BG

Contact name

Rumyana Komitova

E-mail

odisp@abv.bg

Phone

+359 56866404

Fax

+359 56859830

Website

Link

Organization data Organization in JSON